Michael Truett Tate Sells 11,430 Shares of Astera Labs (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALAB) CFO Michael Truett Tate sold 11,430 shares of the business’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $1,653,806.70. Following the transaction, the chief financial officer owned 192,297 shares in the company, valued at $27,823,452.93. The trade was a 5.61% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Michael Truett Tate also recently made the following trade(s):

• On Monday, November 17th, Michael Truett Tate sold 11,430 shares of Astera Labs stock. The stock was sold at an average price of $144.69, for a total transaction of $1,653,806.70.

Astera Labs Stock Up 1.8%

ALAB traded up $2.49 during midday trading on Wednesday, hitting $142.01. The company had a trading volume of 4,125,472 shares, compared to its average volume of 5,263,438. The stock’s 50 day moving average price is $190.50 and its 200 day moving average price is $145.33. Astera Labs, Inc. has a 52 week low of $47.13 and a 52 week high of $262.90. The company has a market capitalization of $23.99 billion, a price-to-earnings ratio of 127.94, a PEG ratio of 2.64 and a beta of 1.37.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The company had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. During the same period last year, the business posted $0.23 EPS. The firm’s revenue for the quarter was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Research analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Analyst Upgrades and Downgrades

ALAB has been the topic of a number of recent research reports. Needham & Company LLC increased their target price on Astera Labs from $205.00 to $220.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Barclays reaffirmed an “equal weight” rating and issued a $155.00 price objective on shares of Astera Labs in a research note on Monday, October 20th. JPMorgan Chase & Co. boosted their target price on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Morgan Stanley raised their price target on shares of Astera Labs from $200.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Finally, Northland Capmk raised Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Monday. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and a consensus target price of $184.82.

Institutional Investors Weigh In On Astera Labs

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in shares of Astera Labs by 14.1% in the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock worth $2,690,907,000 after buying an additional 1,693,918 shares during the last quarter. Alliancebernstein L.P. boosted its position in Astera Labs by 114.2% in the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock worth $501,289,000 after purchasing an additional 4,478,741 shares during the last quarter. Atreides Management LP grew its stake in Astera Labs by 153.3% in the 1st quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock valued at $277,601,000 after purchasing an additional 2,815,614 shares during the period. State Street Corp increased its position in shares of Astera Labs by 9.1% during the 3rd quarter. State Street Corp now owns 2,339,451 shares of the company’s stock valued at $458,065,000 after purchasing an additional 195,992 shares during the last quarter. Finally, Fred Alger Management LLC boosted its holdings in shares of Astera Labs by 13.0% in the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock worth $93,087,000 after buying an additional 179,638 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.